Creatine monohydrate

Creatine Monohydrate: A Comprehensive Reference

1. Identity and Chemical Characterization

Chemical Names and Identifiers

Creatine, also known by its systematic chemical name alpha-methylguanidinoacetic acid (PubChem CID: 586), and its phosphorylated form phosphocreatine (PCr), are essential molecules for the optimal functioning of tissues with high and fluctuating energy demands. As the monohydrate salt, creatine monohydrate carries the molecular formula C₄H₁₁N₃O₃ (PubChem CID: 80116). Creatine is described as N-(aminoiminomethyl)-N-methyl glycine, a naturally occurring compound that, when combined with phosphate, provides energy for cellular metabolism.

Creatine monohydrate is formed by crystallization with water, forming monoclinic prisms that hold one molecule of water per molecule of creatine; this provides a powder containing 87.9% creatine that readily dissociates into creatine and water upon oral ingestion. Accordingly, approximately 88% to 90% of the weight of creatine monohydrate is pure creatine, while the remaining 10% to 12% is the water molecule.

Biosynthesis and Natural Sources

The human body naturally synthesizes creatine from three amino acids — L-arginine, glycine, and L-methionine — combining them in the liver, kidneys, and pancreas, producing roughly 1 gram daily, which is stored in muscle tissue to fuel explosive movements.

Creatine is available from a variety of animal-based foods — from human breast milk and infant formulas to meat, poultry, and fish. The amount of creatine across natural food sources varies from 0.2 g/kg in breast milk to 11.0 g/kg in raw and dried herring fillet; plant-based foods do not contain any creatine. Creatine can be found in the skeletal muscle of most mammals and fish, including beef, chicken, cod, herring, pork, salmon, tuna, and turkey; it is also present in cranberries and milk. Creatine provision from food is expected to contribute approximately 1 g to the daily net yield, and mean intake may vary as a function of gender and age.

Industrial Synthesis

Supplemental creatine monohydrate is a compound produced through chemical synthesis from the raw materials cyanamide and sodium sarcosinate. Creatine can theoretically be obtained from biological material such as meat waste, but this is technically laborious and raises hygienic concerns. Creatine monohydrate manufactured using water as solvent in Germany has produced 99.9% pure creatine monohydrate with no contaminants, under the brand name Creapure®. The type of creatine primarily used in research to establish its safety and efficacy has traditionally been a micronized creatine monohydrate made by AlzChem in Germany under the brand name Creapure®, reported to produce creatine monohydrate that is 99.9% pure — thus typically considered the gold standard.

2. Common Forms and Preparations

The main creatine formulations include creatine monohydrate, creatine anhydrous, and micronized creatine monohydrate; creatine monohydrate is the most common and well-studied form. Other variants include creatine hydrochloride, liquid creatine, buffered creatine (Kre-Alkalyn), creatine ethyl ester, magnesium-chelated creatine, and creatine nitrate, though many of these have not been proven to be more effective than creatine monohydrate.

• Standard creatine monohydrate powder: Creatine monohydrate is typically available as a tasteless and odorless white powder which is combined with a liquid prior to consumption.
• Micronized creatine monohydrate: Micronized creatine is simply regular creatine monohydrate that has been mechanically processed into smaller particles — typically 20 times smaller than regular creatine — improving solubility. This processing does not alter the chemical structure or composition of the creatine molecule itself.
• Creatine anhydrous: Creatine anhydrous offers slightly more creatine per gram than monohydrate by removing water molecules, but shows no proven performance advantages despite its higher concentration.
• Buffered creatine (Kre-Alkalyn): A buffered form of creatine marketed as a more efficacious and safer form than creatine monohydrate; according to its manufacturer, it is a "pH-correct" form that remains more stable in the stomach and is not degraded to creatinine. However, there is little to no evidence that any of the newer forms of creatine are more effective and/or a safer form than creatine monohydrate, whether ingested alone or in combination with other nutrients.
• Liquid creatine: Liquid creatine has been found to be less effective than creatine monohydrate. The reduced effect is likely due to the passive breakdown of creatine over a period of days into creatinine, which occurs when creatine is suspended in solution.

Creatine monohydrate was the first source of creatine marketed as a dietary supplement and remains the most common source of creatine found in dietary supplements. It is considered the gold standard to compare other purported sources of creatine because of its well-known physiochemical properties, high bioavailability, stability, low cost, and the large number of studies demonstrating efficacy and safety.

3. Historical and Traditional Use

Scientific Discovery

In 1832, French scientist Michel Eugène Chevreul made a groundbreaking discovery when he isolated a new organic compound from meat extracts. He named this compound "creatine," derived from the Greek word for meat. At the time, Chevreul did not fully understand the physiological role of his discovery. The concepts of cellular respiration and ATP were still decades away. However, his work laid the essential foundation, establishing that creatine was a natural, foundational component of vertebrate muscle tissue.

German chemist Justus von Liebig, in 1847, replicated Chevreul's findings that creatine can be extracted from animal flesh. Building from this, he discovered that wild animals have more creatine in their muscles than their domestic counterparts, leading him to conclude that the level of activity influenced the amount of creatine produced. Von Liebig also supported his laboratory largely by producing and selling meat broth — the famous Liebig's meat extract or Fleischbrühe in German — which contained about 8% creatine. This was arguably the first attempt to bring creatine supplementation into the public domain.

Early 20th-Century Research

In 1912, researchers Otto Folin and Willey Glover Denis published groundbreaking evidence showing that when humans and animals ingested creatine, the levels stored in their muscles increased significantly. Following on from the 1912 research, 1923 saw findings emerge suggesting that the use of oral creatine in animals promoted nitrogen retention — meaning more protein was accumulating in the muscles, increasing weight gain; when creatine use was stopped, animals lost the added weight. Inspired by these results, in 1926 Alfred Chanutin experimented with humans for the first time.

In 1927, approximately a century after Chevreul's discovery, phosphocreatine (PCr) itself was identified by Eggleton and Eggleton and by Fiske and Subbarow. In the 1920s, scientists detected that when muscle cells are at rest, they store energy from ATP in the form of creatine phosphate.

Anecdotal Pre-Commercial Use

During the mid-20th century, some bodybuilders and weightlifters reportedly resorted to "sweated beef," a method of extracting creatine from meat using hot steam, resulting in a highly creatine-enriched meat juice said among practitioners to be beneficial for muscle growth and performance.

Entry into Modern Supplementation

A seminal study by Professor Harris, Soderlund, and Hultman (1992) showed that creatine supplementation (20 g/day of creatine monohydrate for 5 days) increased intramuscular creatine and phosphocreatine content by approximately 20%. The Western world witnessed a significant surge in creatine supplement use following this period, with a series of groundbreaking studies showing creatine's potential ergogenic effects, particularly among bodybuilders and athletes. In the 1990s, creatine monohydrate became a popular dietary supplement due to its unique function in energy metabolism.

4. Key Constituents and Mechanisms of Action

The Phosphocreatine–ATP System

Creatine and phosphocreatine are physiologically essential molecules for life, serving as rapid and localized support of energy- and mechanical-dependent processes. This evolutionary advantage is based on the action of creatine kinase (CK) isozymes that connect places of ATP synthesis with sites of ATP consumption — known as the CK/PCr system.

Creatine monohydrate supplementation can increase the phosphocreatine/creatine ratio in skeletal muscle tissue, thereby increasing the capacity for rapid adenosine triphosphate (ATP) resynthesis during repeated high-intensity exercise tasks. This reaction is catalyzed by the enzyme creatine kinase (CK), which is found in different isoforms; in skeletal muscle, the MM-CK isoform is expressed, while in the brain, the BB-CK isoform is expressed. Creatine is also responsible for energy transfer from the mitochondria, a major site of ATP resynthesis, to the cytosol, a major site of ATP utilization. Due to this role, creatine is known as a spatial energy buffer.

Ergogenic Mechanisms

The primary mechanism explaining the acute ergogenic value of creatine supplementation is an enlargement of the phosphagen pool available for rapid resynthesis of ATP during periods of extremely high ATP demand. In the phosphorylated form, creatine serves as an energy substrate that contributes to the resynthesis of adenosine triphosphate (ATP) during maximal exercise.

An increase in the rate of phosphocreatine resynthesis during recovery between bouts of exercise, and thus higher phosphocreatine levels at the start of the subsequent exercise bout, is believed to be the primary mechanism explaining the ergogenic effects of creatine supplementation during intense, intermittent protocols.

Recovery after high-intensity exercise involves a resynthesis of phosphocreatine, which occurs via an oxygen-dependent process with a half-life of approximately 30 seconds.

Cell Hydration and Anabolic Signaling

The increase in lean mass following creatine supplementation has at least partly been attributed to water retention in muscle tissue. Greater osmotic pressure following the increase in creatine content has been suggested to result in muscle cell swelling, which is considered a key stimulus for cell growth.

A number of mechanisms have been proposed to explain the benefit that creatine monohydrate has on resistance training-induced adaptations, including larger lean body mass, increased protein expression and synthesis, changes in myogenic transcription factors, and elevated mitotic activity of satellite cells.

Creatinine Degradation

The loss of creatine from skeletal muscle is typically about 3% per day, which closely matches the amount of creatinine non-enzymatically produced by living human muscle. The main mechanism by which creatine is lost is the conversion of creatine to creatinine, which is an irreversible non-enzymatic process.

5. Scientific Evidence by Area of Use

5.1 High-Intensity Exercise Performance

In a position statement, the Academy of Nutrition and Dietetics (AND), Dietitians of Canada (DoC), and American College of Sports Medicine (ACSM) advise that creatine enhances performance of cycles of high-intensity exercise followed by short recovery periods and improves training capacity. In its own position statement, the International Society of Sports Nutrition (ISSN) states that creatine monohydrate is the most effective nutritional supplement currently available for enhancing capacity for high-intensity exercise and lean body mass during exercise.

Studies involving participants engaged in sports such as soccer, combat sports, and some racquet sports have shown benefits from using creatine monohydrate for short, high-intensity exercise to increase power, speed, and jump performance. Systematic reviews report increased weight lifted during squats, leg press, and bench press among recreationally trained or competitive athletes for exercise durations less than 3 minutes.

The rate of phosphocreatine resynthesis can be accelerated by the use of creatine supplementation in subjects who demonstrate an increase in creatine concentration. The benefits of creatine supplementation are particularly evident in high-intensity activities that are intermittent in nature.

Evidence strength: Strong. This is the most robustly supported application of creatine monohydrate, supported by multiple systematic reviews and the position statements of major sports nutrition and dietetics bodies.

5.2 Muscle Strength and Lean Mass

Results from meta-analyses have collectively shown that creatine combined with resistance training increased measures of lean tissue mass by approximately 1.2 kg and increased strength measures (leg press, chest press) more than placebo and resistance training alone.

Creatine monohydrate is the most popular nutritional supplement used by athletes and is increasingly used in combination with resistance training to preserve or increase lean tissue mass and muscle strength in older adults. An increase in body mass ranging from 1 to 3 kg is common after 1 week of creatine supplementation, attributable to an increase in total body water.

Above all, the most likely benefit appears to be due to improved performance during resistance training sessions by increasing intramuscular phosphocreatine stores, thereby allowing greater work capacity and thus training stimuli for enhanced chronic training adaptation.

Evidence strength: Strong. Multiple meta-analyses of randomized controlled trials confirm meaningful increases in muscle strength and lean mass, particularly when creatine monohydrate is combined with resistance training.

5.3 Muscle Damage and Recovery

Recent evidence also suggests the potential for creatine monohydrate supplementation to attenuate muscle damage markers as an acute response to exercise. A systematic review and meta-analysis investigating this effect included 23 studies, comprising 240 participants in the creatine monohydrate group and 229 in the placebo group; these studies were rated as fair to excellent following the PEDro scale.

Evidence strength: Moderate. There is emerging evidence for attenuation of exercise-induced muscle damage markers, though the mechanistic explanation remains under investigation.

5.4 Lean Mass and Muscle in Older Adults (Sarcopenia)

Independent of pharmacological interventions, resistance training is effective for increasing lean tissue mass and muscular strength in older adults, with nutritional interventions including creatine further augmenting these beneficial effects on muscle.

Creatine supplementation, particularly when combined with resistance training, significantly improves muscle strength, lean body mass, and functional capacity in older adults. Creatine monohydrate has potential to prevent falls through improvement in neural function, or improvement in muscle quality, both of which can affect motor ability and therefore reduce susceptibility of falling in older adults.

Evidence strength: Strong for combined creatine plus resistance training. Multiple meta-analyses of randomized controlled trials in populations aged 50 and over consistently show meaningful improvements in lean tissue mass and strength.

5.5 Cognitive Function and Brain Health

Creatine intake has garnered increasing scholarly attention regarding its potential to augment cognitive performance, especially within the realms of attention, memory, and processing speed, while concurrently piquing interest in its neuroprotective capabilities during the aging process.

A meta-analysis encompassing 16 trials (n = 492; ages 20.8–76.4 years) assessed the impact of creatine monohydrate on cognitive function among adults. The outcomes indicated notable enhancements in memory (SMD = 0.31), attention time (SMD = −0.31), and processing speed (SMD = −0.51), although no significant impacts were observed on overall cognitive or executive functioning.

Five of six (83.3%) studies examining creatine and cognition in older adults reported a positive relationship, particularly in the domains of memory and attention. However, only one study achieved a methodological quality rating of "good," two "fair," and three "poor." The current limited evidence suggests that creatine may be associated with benefits for cognition in generally healthy older adults, though high-quality clinical trials are warranted to further validate this relationship.

Creatine crosses the blood-brain barrier and may be protective for brain health with aging. In a model of aged mice, creatine monohydrate tended to reduce reactive oxygen species in the brain, reduced "lipofuscin" (an aging pigment), upregulated genes associated with neuronal growth, neuroprotection, and learning, and tended to improve function on a locomotor task.

A limitation in this literature is the generally small sample sizes of many clinical trials, often ranging from fewer than 10 to fewer than 50 participants, which restricts statistical power. Although meta-analyses provide a broader perspective, the overall quality of evidence for creatine's effects on cognition is typically rated as moderate to low.

Evidence strength: Preliminary to moderate. Positive signals are present in meta-analyses for memory, attention, and processing speed, but the methodological quality of many constituent trials is limited. Larger, well-controlled RCTs are needed.

5.6 Creatine in Alzheimer's Disease

Preclinical studies indicate that creatine monohydrate supplementation enhances cognition and reduces pathological biomarkers in mouse models of Alzheimer's disease (AD). In a single-arm pilot trial, 20 g/day of creatine monohydrate for 8 weeks was investigated in 20 patients with AD. This pilot study demonstrated that creatine monohydrate supplementation was feasible in AD and was associated with increased brain total creatine levels and improved cognition, suggesting that creatine may offer bioenergetic and cognitive benefits in AD. Larger efficacy trials are needed to investigate creatine monohydrate supplementation as a potential therapy and to determine the optimal dose.

Evidence strength: Very preliminary. Only preclinical data and a small single-arm pilot trial are available. No conclusion about efficacy in AD can be drawn at this stage.

5.7 Therapeutic and Clinical Applications

The ISSN recognizes that creatine monohydrate may have therapeutic applications in neurodegenerative diseases, diabetes, muscle-wasting conditions, and brain health. Supplementation with creatine monohydrate can enhance the CK/PCr system, resulting in well-known ergogenic effects and potential health or therapeutic benefits. However, further clinical research is needed to validate the proposed mechanisms in health and disease conditions.

Evidence strength: Emerging and variable by condition. Therapeutic applications beyond exercise performance and muscle aging remain under active investigation and require larger human trials.

6. Body Systems Associated with Creatine Monohydrate

• Musculoskeletal system: Primary locus of creatine storage and action; directly supports phosphocreatine-mediated ATP resynthesis in skeletal muscle during high-intensity contractions; augments lean mass and muscle strength, particularly in combination with resistance training.
• Nervous system / Brain: The BB-CK isoform of creatine kinase is expressed in the brain, indicating a role for the phosphocreatine system in neural energy homeostasis. Creatine supplementation has been associated with improvements in memory, attention, and processing speed in clinical studies.
• Renal / Urinary system: Creatinine — the irreversible breakdown product of creatine — is filtered and excreted by the kidneys, making the renal system the primary route of creatine elimination.
• Cardiovascular / Metabolic system: Creatine is responsible for energy transfer from the mitochondria to the cytosol, functioning as a spatial energy buffer across tissues with high energetic demand.

7. Dosage Forms and Dosages Reported in Studies

Bioavailability

Creatine monohydrate is the most common form of creatine and the default form used in most studies. It has high intestinal absorption, with bioavailability of approximately 99% at standard doses of 5–10 g. There is evidence to suggest that high acute doses greater than 10 g can saturate intestinal uptake, lowering absorption and increasing fecal secretion.

Studies have indicated that creatine monohydrate is not degraded during normal digestion and that nearly 99% of orally ingested creatine is either taken up by tissues or excreted in urine.

Loading Protocol

Studies suggest taking 5 g of creatine monohydrate four or five times daily for 5 to 7 days is the most effective way to increase muscle creatine levels rapidly; however, recommended amounts may vary depending on body weight. For larger athletes, the loading dose may be calculated as 0.3 g/kg/day.

Maintenance Protocol

After the loading phase, 3 to 5 g doses daily are used to maintain creatine stores. A regimen of 3–5 g/day without loading reaches similar muscle saturation levels in roughly 3–4 weeks.

Older Adults Protocol (Reported in Trials)

In one randomized controlled trial examining older adults, participants were supplemented with creatine monohydrate at 4 × 5 g/day for five days followed by 5 g/day for 24 weeks.

Alzheimer's Disease Pilot Protocol

A single-arm pilot trial investigated 20 g/day of creatine monohydrate for 8 weeks in 20 patients with Alzheimer's disease.

Seminal Muscle Loading Study

The landmark study by Harris, Soderlund, and Hultman (1992) used 20 g/day of creatine monohydrate for 5 days, which increased intramuscular creatine and phosphocreatine content by approximately 20%.

Daily Creatine Need

The daily creatine need of the body is approximately 2–4 grams per day. To maintain normal creatine levels, the body requires daily replenishment of about 1–3 g; creatine supplementation is particularly beneficial for vegetarians with lower intramuscular creatine stores and athletes engaged in intense training who may require higher amounts.

Timing

Post-exercise creatine intake may confer more significant benefits than pre-exercise consumption, as exercise-induced blood flow to muscles enhances nutrient delivery and uptake. When combined with carbohydrates or proteins, creatine absorption can be further augmented due to insulin-mediated transport mechanisms.

8. Safety Considerations and Interactions

General Safety Profile

According to decades of research and position statements from respected organizations like the International Society of Sports Nutrition (ISSN), creatine monohydrate is considered safe for healthy individuals when taken at recommended doses. The ISSN contends that athletes who supplement with creatine have a lower incidence of injuries and exercise-related side effects compared to those who do not take creatine.

Renal Function

Creatine monohydrate is a widely used dietary supplement with proven benefits in athletic performance and potential therapeutic applications, but concerns regarding its impact on renal function persist, largely due to elevated serum creatinine levels associated with creatine intake. However, the elevated creatinine from supplementation does not indicate kidney damage.

Findings from reviewed studies consistently showed no evidence of renal function impairments based on several parameters (including estimated GFR, serum and urinary creatinine, urea, proteinuria, and albuminuria) following a wide range of supplementation protocols (1–80 g/day of creatine monohydrate for varying durations).

In response to concerns regarding creatine and renal toxicity, Poortmans conducted studies of the effect of creatine supplementation on renal function, showing that short-term supplementation does not alter glomerular filtration rate, and that chronic supplementation of up to five years' duration did not impair renal function in healthy athletes.

In terms of kidney health, studies consistently show no adverse effects on renal function in healthy individuals, though caution is advised for those with pre-existing kidney conditions and pregnant women, as evidence is lacking for these populations.

Cancer Risk

Although some theoretical risks, such as creatine's potential to form carcinogenic compounds, have been discussed, the available research does not support a link between creatine supplementation and cancer.

Dehydration and Muscle Cramps

Claims that creatine leads to dehydration or muscle cramps during exercise are largely unsupported by controlled studies, which demonstrate no significant effects on hydration status.

Gastrointestinal Effects

Gastrointestinal distress is reported in some individuals, particularly at high doses, but such effects are dose-dependent and not universally experienced. Overall, the evidence suggests that creatine monohydrate supplementation is generally safe when used appropriately.

Body Mass and Water Retention

An increase in body mass ranging from 1 to 3 kg is common after 1 week of creatine supplementation, attributable to an increase in total body water. This is a consequence of creatine's osmotic effect on muscle cells, not fat accumulation.

Comparison of Forms — Safety and Regulatory Status

There is little to no evidence that any of the newer forms of creatine are more effective and/or safer than creatine monohydrate, whether ingested alone or in combination with other nutrients. Furthermore, whereas the safety, efficacy, and regulatory status of creatine monohydrate is clearly defined in almost all global markets, the safety, efficacy, and regulatory status of other forms of creatine present in today's marketplace are less clear.

Special Populations

The efficacy, safety, and regulatory status of most newer forms of creatine found in dietary supplements have not been well-established. With respect to creatine monohydrate specifically, the safety data in pregnant women and individuals with pre-existing kidney disease is insufficient to draw firm conclusions, and specific guidance for these populations is not established in the peer-reviewed literature.

References

• PubChem: Creatine Monohydrate (CID 80116) — National Library of Medicine
• FDA GRAS Notice No. GRN 931: Creatine Monohydrate (Creapure®)
• Lanhers C et al. Creatine Supplementation for Muscle Growth: A Scoping Review of Randomized Clinical Trials from 2012 to 2021. Nutrients, PMC, 2022.
• A Convergent Functional Genomics Analysis to Identify Biological Regulators Mediating Effects of Creatine Supplementation. PMC / Front. Physiol., 2021.
• Creatine Phosphate — ScienceDirect Topics (overview with primary references including Harris et al. 1992)
• Bemben MG, Lamont HS. Creatine Supplementation: Its Role in Human Performance. Clinics in Sports Medicine, 2005.
• Wax B et al. The Paradoxical Effect of Creatine Monohydrate on Muscle Damage Markers: A Systematic Review and Meta-Analysis. Nutrients, PMC, 2022.
• Chilibeck PD et al. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access Journal of Sports Medicine, PMC, 2017.
• Candow DG et al. Meta-Analysis Examining the Importance of Creatine Ingestion Strategies on Lean Tissue Mass and Strength in Older Adults. Nutrients, PMC, 2021.
• Systematic Review: Creatine and Cognition in Aging — Evidence in Older Adults. Nutrition Reviews, PubMed, 2025.
• Xu C et al. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Frontiers in Nutrition, PMC, 2024.
• Creatine supplementation and exercise in aging: a narrative review of the muscle–brain axis. Frontiers in Nutrition, 2025.
• Smith et al. Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2025.
• Creatine monohydrate supplementation for older adults and clinical populations. PMC, 2025.
• Effect of creatine supplementation on kidney function: a systematic review and meta-analysis. PMC, 2025.
• A short review of the most common safety concerns regarding creatine ingestion. PMC, 2025.
• Jagim AR et al. A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate. J Int Soc Sports Nutr, PMC, 2012.
• Kreider RB et al. Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review. Nutrients, MDPI, 2022.
• Analysis of the efficacy, safety, and cost of alternative forms of creatine available for purchase on Amazon.com. PMC / J Int Soc Sports Nutr, 2022.
• Creatine as a food supplement for the general population. Journal of Functional Foods, ScienceDirect, 2021.
• Examine.com: What are the main creatine formulations and variants?
• NIH Office of Dietary Supplements: Dietary Supplements for Exercise and Athletic Performance — Health Professional Fact Sheet
• Operation Supplement Safety (OPSS / DoD): Creatine Monohydrate: Dietary Supplement for Performance
• Creatine For Health: Creatine History — Discovery and First Trials with Creatine Supplementation
• Effects of creatine supplementation on muscle strength gains — a meta-analysis and systematic review. PMC, 2025.
• Liu SC et al. The impact of creatine supplementation associated with resistance training on muscular strength and lean tissue mass in the aged: a systematic review and meta-analysis. European Review of Aging and Physical Activity, PMC, 2025.